SUSRF vs PFE: Which Stock is Better?
Side-by-side comparison of Surgical Science Sweden AB (publ) and Pfizer Inc in 2026
SUSRF
Surgical Science Sweden AB (publ)
$2.84
PFE
Pfizer Inc
$27.56
Key Metrics Comparison
| Metric | SUSRF | PFE | Winner |
|---|---|---|---|
| Market Cap | $150.36M | $156.77B | PFE |
| P/E Ratio | 20.29 | 19.97 | PFE |
| EPS (TTM) | $0.14 | $1.38 | PFE |
| Revenue Growth | 0.1% | -0.0% | SUSRF |
| Gross Margin | 66.6% | 75.8% | PFE |
Analyze SUSRF
Full quant analysis
Analyze PFE
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SUSRF or PFE a better investment?
Comparing SUSRF and PFE: Surgical Science Sweden AB (publ) has a market cap of $150.36M while Pfizer Inc has $156.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SUSRF and PFE?
SUSRF (Surgical Science Sweden AB (publ)) and PFE (Pfizer Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SUSRF or PFE?
Based on P/E ratios, PFE trades at a lower multiple (20.0x vs 20.3x).
Which is growing faster: SUSRF or PFE?
SUSRF has higher revenue growth at 0.1% vs -0.0% for PFE.
Which company is more profitable: SUSRF or PFE?
Pfizer Inc (PFE) has higher gross margins at 75.8% compared to 66.6% for SUSRF.
Which is the larger company: SUSRF or PFE?
Pfizer Inc (PFE) is larger with a market cap of $156.77B compared to $150.36M for SUSRF.
Should I buy SUSRF or PFE in 2026?
Both SUSRF and PFE have investment merit. SUSRF trades at $2.84 while PFE trades at $27.56. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SUSRF and PFE stock?
Key differences: Market Cap ($150.36M vs $156.77B), P/E Ratio (20.3x vs 20.0x), Revenue Growth (0.1% vs -0.0%), Gross Margin (66.6% vs 75.8%).